550 related articles for article (PubMed ID: 8504432)
1. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions.
Yeo KT; Wang HH; Nagy JA; Sioussat TM; Ledbetter SR; Hoogewerf AJ; Zhou Y; Masse EM; Senger DR; Dvorak HF
Cancer Res; 1993 Jun; 53(12):2912-8. PubMed ID: 8504432
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation.
Nagy JA; Masse EM; Herzberg KT; Meyers MS; Yeo KT; Yeo TK; Sioussat TM; Dvorak HF
Cancer Res; 1995 Jan; 55(2):360-8. PubMed ID: 7812969
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
[TBL] [Abstract][Full Text] [Related]
4. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.
Abu-Jawdeh GM; Faix JD; Niloff J; Tognazzi K; Manseau E; Dvorak HF; Brown LF
Lab Invest; 1996 Jun; 74(6):1105-15. PubMed ID: 8667614
[TBL] [Abstract][Full Text] [Related]
5. Differential inhibition of fluid accumulation and tumor growth in two mouse ascites tumors by an antivascular endothelial growth factor/permeability factor neutralizing antibody.
Luo JC; Toyoda M; Shibuya M
Cancer Res; 1998 Jun; 58(12):2594-600. PubMed ID: 9635584
[TBL] [Abstract][Full Text] [Related]
6. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract.
Brown LF; Berse B; Jackman RW; Tognazzi K; Manseau EJ; Senger DR; Dvorak HF
Cancer Res; 1993 Oct; 53(19):4727-35. PubMed ID: 8402650
[TBL] [Abstract][Full Text] [Related]
7. Significant expression of vascular endothelial growth factor/vascular permeability factor in mouse ascites tumors.
Luo JC; Yamaguchi S; Shinkai A; Shitara K; Shibuya M
Cancer Res; 1998 Jun; 58(12):2652-60. PubMed ID: 9635593
[TBL] [Abstract][Full Text] [Related]
8. Vascular permeability factor gene expression in normal and neoplastic human ovaries.
Olson TA; Mohanraj D; Carson LF; Ramakrishnan S
Cancer Res; 1994 Jan; 54(1):276-80. PubMed ID: 8261452
[TBL] [Abstract][Full Text] [Related]
9. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor levels and induction of permeability in malignant pleural effusions.
Zebrowski BK; Yano S; Liu W; Shaheen RM; Hicklin DJ; Putnam JB; Ellis LM
Clin Cancer Res; 1999 Nov; 5(11):3364-8. PubMed ID: 10589746
[TBL] [Abstract][Full Text] [Related]
11. Soluble aminopeptidase N/CD13 in malignant and nonmalignant effusions and intratumoral fluid.
van Hensbergen Y; Broxterman HJ; Hanemaaijer R; Jorna AS; van Lent NA; Verheul HM; Pinedo HM; Hoekman K
Clin Cancer Res; 2002 Dec; 8(12):3747-54. PubMed ID: 12473585
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor is increased in ascites from metastatic pancreatic cancer.
Liu CD; Tilch L; Kwan D; McFadden DW
J Surg Res; 2002 Jan; 102(1):31-4. PubMed ID: 11792148
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of vascular permeability factor (vascular endothelial growth factor) with antipeptide antibodies.
Sioussat TM; Dvorak HF; Brock TA; Senger DR
Arch Biochem Biophys; 1993 Feb; 301(1):15-20. PubMed ID: 8442657
[TBL] [Abstract][Full Text] [Related]
15. Suppression of ascites formation and re-accumulation associated with human ovarian cancer by an anti-VPF monoclonal antibody in vivo.
Yukita A; Asano M; Okamoto T; Mizutani S; Suzuki H
Anticancer Res; 2000; 20(1A):155-60. PubMed ID: 10769648
[TBL] [Abstract][Full Text] [Related]
16. Tumor-secreted vascular permeability factor/vascular endothelial growth factor influences photosensitizer uptake.
Roberts WG; Hasan T
Cancer Res; 1993 Jan; 53(1):153-7. PubMed ID: 8416739
[TBL] [Abstract][Full Text] [Related]
17. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma.
Guidi AJ; Abu-Jawdeh G; Tognazzi K; Dvorak HF; Brown LF
Cancer; 1996 Aug; 78(3):454-60. PubMed ID: 8697391
[TBL] [Abstract][Full Text] [Related]
18. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines.
Senger DR; Perruzzi CA; Feder J; Dvorak HF
Cancer Res; 1986 Nov; 46(11):5629-32. PubMed ID: 3756910
[TBL] [Abstract][Full Text] [Related]
19. Uterine smooth muscle cells express functional receptors (flt-1 and KDR) for vascular permeability factor/vascular endothelial growth factor.
Brown LF; Detmar M; Tognazzi K; Abu-Jawdeh G; Iruela-Arispe ML
Lab Invest; 1997 Feb; 76(2):245-55. PubMed ID: 9042161
[TBL] [Abstract][Full Text] [Related]
20. Influence of microvessel density and vascular permeability factor/vascular endothelial growth factor expression on prognosis in vulvar cancer.
Obermair A; Kohlberger P; Bancher-Todesca D; Tempfer C; Sliutz G; Leodolter S; Reinthaller A; Kainz C; Breitenecker G; Gitsch G
Gynecol Oncol; 1996 Nov; 63(2):204-9. PubMed ID: 8910628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]